199 related articles for article (PubMed ID: 11947914)
1. Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters.
Rothenbacher D; Fischer HG; Hoffmeister A; Hoffmann MM; März W; Bode G; Rosenthal J; Koenig W; Brenner H
Atherosclerosis; 2002 May; 162(1):193-200. PubMed ID: 11947914
[TBL] [Abstract][Full Text] [Related]
2. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
Hanson NQ; Aras O; Yang F; Tsai MY
Clin Chem; 2001 Apr; 47(4):661-6. PubMed ID: 11274015
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk in UK Indian Asians.
Chambers JC; Ireland H; Thompson E; Reilly P; Obeid OA; Refsum H; Ueland P; Lane DA; Kooner JS
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2448-52. PubMed ID: 11073851
[TBL] [Abstract][Full Text] [Related]
4. The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism.
Mehlig K; Leander K; de Faire U; Nyberg F; Berg C; Rosengren A; Björck L; Zetterberg H; Blennow K; Tognon G; Torén K; Strandhagen E; Lissner L; Thelle D
Heart; 2013 Dec; 99(23):1761-5. PubMed ID: 24014284
[TBL] [Abstract][Full Text] [Related]
5. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease.
Anderson JL; Muhlestein JB; Horne BD; Carlquist JF; Bair TL; Madsen TE; Pearson RR
Circulation; 2000 Sep; 102(11):1227-32. PubMed ID: 10982535
[TBL] [Abstract][Full Text] [Related]
6. MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.
Klerk M; Verhoef P; Clarke R; Blom HJ; Kok FJ; Schouten EG;
JAMA; 2002 Oct 23-30; 288(16):2023-31. PubMed ID: 12387655
[TBL] [Abstract][Full Text] [Related]
7. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study.
Ou T; Yamakawa-Kobayashi K; Arinami T; Amemiya H; Fujiwara H; Kawata K; Saito M; Kikuchi S; Noguchi Y; Sugishita Y; Hamaguchi H
Atherosclerosis; 1998 Mar; 137(1):23-8. PubMed ID: 9568733
[TBL] [Abstract][Full Text] [Related]
9. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
[TBL] [Abstract][Full Text] [Related]
10. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study.
Dekou V; Whincup P; Papacosta O; Ebrahim S; Lennon L; Ueland PM; Refsum H; Humphries SE; Gudnason V
Atherosclerosis; 2001 Feb; 154(3):659-66. PubMed ID: 11257267
[TBL] [Abstract][Full Text] [Related]
11. The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.
Verhoef P; Kok FJ; Kluijtmans LA; Blom HJ; Refsum H; Ueland PM; Kruyssen DA
Atherosclerosis; 1997 Jul; 132(1):105-13. PubMed ID: 9247365
[TBL] [Abstract][Full Text] [Related]
12. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
Chango A; Potier De Courcy G; Boisson F; Guilland JC; Barbé F; Perrin MO; Christidès JP; Rabhi K; Pfister M; Galan P; Hercberg S; Nicolas JP
Br J Nutr; 2000 Dec; 84(6):891-6. PubMed ID: 11177206
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians.
Ma J; Stampfer MJ; Hennekens CH; Frosst P; Selhub J; Horsford J; Malinow MR; Willett WC; Rozen R
Circulation; 1996 Nov; 94(10):2410-6. PubMed ID: 8921781
[TBL] [Abstract][Full Text] [Related]
14. High cysteine levels in renal transplant recipients: relationship with hyperhomocysteinemia and 5,10-MTHFR polymorphism.
Marcucci R; Fedi S; Brunelli T; Pepe G; Prisco D; Rosati A; Zanazzi M; Bertoni E; Abbate R; Salvadori M
Transplantation; 2001 Mar; 71(6):746-51. PubMed ID: 11330536
[TBL] [Abstract][Full Text] [Related]
15. Thermolabile MTHFR genotype and retinal vascular occlusive disease.
Cahill M; Karabatzaki M; Donoghue C; Meleady R; Mynett-Johnson LA; Mooney D; Graham IM; Whitehead AS; Shields DC
Br J Ophthalmol; 2001 Jan; 85(1):88-90. PubMed ID: 11133719
[TBL] [Abstract][Full Text] [Related]
16. The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine values.
Rodríguez-Esparragón F; Hernández-Perera O; Rodríguez-Pérez JC; Anábitarte A; Díaz-Cremades JM; Losada A; Fiuza D; Hernández E; Yunis C; Ferrario CM
Clin Exp Hypertens; 2003 May; 25(4):209-20. PubMed ID: 12797595
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
[TBL] [Abstract][Full Text] [Related]
18. [Homocysteine, methylenetetrahydrofolate reductase/C677T genotype and risk for coronary heart disease. The AtheroGene study].
Blankenberg S; Rupprecht HJ; Peetz D; Bickel C; Hofman KP; Tiret L; Meyer J
Dtsch Med Wochenschr; 2002 Apr; 127(14):729-35. PubMed ID: 11935469
[No Abstract] [Full Text] [Related]
19. MTHFR C677T and A1298C gene polymorphisms and their relation to homocysteine level in Egyptian children with congenital heart diseases.
Zidan HE; Rezk NA; Mohammed D
Gene; 2013 Oct; 529(1):119-24. PubMed ID: 23933414
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase (MTHFR) 677C>T and methionine synthase reductase (MTRR) 66A>G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid.
Brilakis ES; Berger PB; Ballman KV; Rozen R
Atherosclerosis; 2003 Jun; 168(2):315-22. PubMed ID: 12801615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
